Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CCDC50 encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Additionally we are shipping Coiled-Coil Domain Containing 50 Kits (12) and Coiled-Coil Domain Containing 50 Proteins (4) and many more products for this protein.
Showing 10 out of 86 products:
Chicken Polyclonal CCDC50 Primary Antibody for WB - ABIN2785358
Bohgaki, Tsukiyama, Nakajima, Maruyama, Watanabe, Koike, Hatakeyama: Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain. in Biochimica et biophysica acta 2008
Human Polyclonal CCDC50 Primary Antibody for EIA, IHC (fro) - ABIN1109531
Modamio-Hoybjor, Mencia, Goodyear, del Castillo, Richardson, Moreno, Moreno-Pelayo: A mutation in CCDC50, a gene encoding an effector of epidermal growth factor-mediated cell signaling, causes progressive hearing loss. in American journal of human genetics 2007
Human Polyclonal CCDC50 Primary Antibody for IHC (p), IHC - ABIN250431
Blagoev, Ong, Kratchmarova, Mann: Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. in Nature biotechnology 2004
Up to now, merely 7 loci have been linked to mid-frequency hearing loss. Only four genetic mid-frequency deafness genes, namely, DFNA10 (EYA4 (show EYA4 Antibodies)), DFNA8 (show TECTA Antibodies)/12 (TECTA (show TECTA Antibodies)), DFNA13 (COL11A2 (show COL11A2 Antibodies)), DFNA44 (CCDC50), have been reported to date. [review]
Ymer acts as a regulator downstream of several receptors and that Ymer functions as a positive or negative regulator in a signaling pathway-dependent manner.
identification of a novel DFNA locus on chromosome 3q28-29 in a Spanish family with postlingual and progressive hearing loss[DFNA44]
Ymer functions as a novel inhibitor for the down-regulation of the EGF receptor (show EGFR Antibodies) and plays a crucial role for regulating the amount of the EGF receptor (show EGFR Antibodies) on the cell surface membrane
These findings demonstrate that Ymer is likely to be a negative regulator for the NF-kappaB (show NFKB1 Antibodies) signaling pathway.
CCDC50 is required for survival in mantle cell lymphoma and chronic lymphocytic leukemia cells and controls NFkappaB signaling
This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
coiled-coil domain containing 50
, Ymer protein
, coiled-coil domain-containing protein 50
, protein Ymer
, putative C3orf6 protein homolog